http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14953335
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
703
issn
1442-2042
0919-8172
issueIdentifier
6
pageRange
702-703
publicationName
International journal of urology : official journal of the Japanese Urological Association
startingPage
702
bibliographicCitation
Suzuki K, Hara T, Terakawa T, Harada K, Fujisawa M. Efficacy of axitinib rechallenge in metastatic renal cell carcinoma. Int J Urol. 2021 Jun;28(6):702–3. doi: 10.1111/iju.14529. PMID: 33719092.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1fbcc4d172ef345ee31350cf6afa235
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01e2e064236bcaac777d8362b75c821e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b782bc55c38b6347e7885e1609bd40b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4589-9251
date
2021-03-14-04:00
^^<
http://www.w3.org/2001/XMLSchema#date
>
identifier
https://doi.org/10.1111/iju.14529
https://pubmed.ncbi.nlm.nih.gov/33719092
isPartOf
https://portal.issn.org/resource/ISSN/0919-8172
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8739
https://portal.issn.org/resource/ISSN/1442-2042
language
English
source
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title
Efficacy of axitinib rechallenge in metastatic renal cell carcinoma
discusses
http://id.nlm.nih.gov/mesh/M0489638
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0011208
hasPrimarySubjectTerm
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D002292Q000188
http://id.nlm.nih.gov/mesh/D007680Q000188
hasSubjectTerm
http://id.nlm.nih.gov/mesh/D007191Q000009
http://id.nlm.nih.gov/mesh/D047428Q000009
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D000077784Q000009
http://id.nlm.nih.gov/mesh/D006801
Total number of triples:
36
.